{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:54:58Z","timestamp":1794970498697,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.vaccine.2008.09.063","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T17:30:41Z","timestamp":1224091841000},"page":"6901-6907","source":"Crossref","is-referenced-by-count":50,"title":["Antibodies and cytokines independently protect against pneumonic plague"],"prefix":"10.1016","volume":"26","author":[{"given":"Lawrence W.","family":"Kummer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Szaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Adamovicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Smiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2008.09.063_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis-etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.09.063_bib2","series-title":"The prokaryotes, an evolving electronic resource for the microbiological community","article-title":"Yersinia pestis and bubonic plague","author":"Brubaker","year":"2000"},{"key":"10.1016\/j.vaccine.2008.09.063_bib3","unstructured":"Pollitzer R. Plague. World Health Organization Monograph Series, vol. 22, World Health Organization, Geneva, 1954."},{"key":"10.1016\/j.vaccine.2008.09.063_bib4","unstructured":"Dennis DT, Gage KL, Gratz N, Poland JD, Tikhomirov E. Plague Manual: Epidemiology, Distribution, Surveillance and Control WHO\/CDS\/CSR\/EDC\/99.2. World Health Organization, 1999."},{"issue":"9568","key":"10.1016\/j.vaccine.2008.09.063_bib5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(07)60566-2","article-title":"Plague","volume":"369","author":"Prentice","year":"2007","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.vaccine.2008.09.063_bib6","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2008.09.063_bib7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1086\/428617","article-title":"Risk of person-to-person transmission of pneumonic plague","volume":"40","author":"Kool","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.063_bib8","series-title":"Bioterrorism and infectious agents: a new dilemma for the 21st century","first-page":"37","article-title":"Plague as a biological weapon","author":"Dennis","year":"2005"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.063_bib9","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2008.09.063_bib10","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.vaccine.2007.01.071","article-title":"Development of a recombinant vaccine against aerosolized plague","volume":"25","author":"Morris","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.063_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.063_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","article-title":"Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis","volume":"56","author":"Anderson","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.063_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-695X.1999.tb01229.x","article-title":"The SCID\/Beige mouse as a model to investigate protection against Yersinia pestis","volume":"23","author":"Green","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.063_bib14","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.063_bib15","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/IAI.74.5.3068-3070.2006","article-title":"Administration of antibody to the lung protects mice against pneumonic plague","volume":"74","author":"Hill","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.063_bib16","unstructured":"Pitt ML. Non-human primates as a model for pneumonic plague. In: Animals models and correlates of protection for plague vaccines workshop. http:\/\/www.fda.gov\/cber\/minutes\/plague101304t.pdf, Gaithersburg, MD, 2004."},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.063_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00398-06","article-title":"Development of in vitro correlate assays of immunity to infection with Yersinia pestis","volume":"14","author":"Bashaw","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.063_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb Pathog"},{"issue":"13","key":"10.1016\/j.vaccine.2008.09.063_bib19","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.vaccine.2008.01.033","article-title":"Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague","volume":"26","author":"Zauberman","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.09.063_bib20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1128\/CVI.00091-08","article-title":"Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection","volume":"15","author":"Welkos","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2008.09.063_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.49.1.15","article-title":"Studies on plague immunity in experimental animals. II. Some factors of the immunity mechanism in bubonic plague","volume":"49","author":"Jawetz","year":"1944","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.063_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4049\/jimmunol.64.3.139","article-title":"Immunity in plague: a critical consideration of some recent studies","volume":"64","author":"Meyer","year":"1950","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.063_bib23","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.00185-06","article-title":"Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection","volume":"74","author":"Parent","year":"2006","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2008.09.063_bib24","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1128\/IAI.66.12.5755-5762.1998","article-title":"Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix","volume":"66","author":"Lahteenmaki","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.063_bib25","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"11","key":"10.1016\/j.vaccine.2008.09.063_bib26","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2008.09.063_bib27","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization","volume":"65","author":"Hill","year":"1997","journal-title":"Infect Immun"},{"issue":"6317","key":"10.1016\/j.vaccine.2008.09.063_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/350423a0","article-title":"A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene","volume":"350","author":"Kitamura","year":"1991","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.063_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/IAI.61.1.23-31.1993","article-title":"Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha","volume":"61","author":"Nakajima","year":"1993","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.063_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2004.06.009","article-title":"Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague","volume":"37","author":"Elvin","year":"2004","journal-title":"Microb Pathog"},{"issue":"49","key":"10.1016\/j.vaccine.2008.09.063_bib31","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1073\/pnas.0506840102","article-title":"Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity","volume":"102","author":"Lathem","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5811","key":"10.1016\/j.vaccine.2008.09.063_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.1137195","article-title":"A plasminogen-activating protease specifically controls the development of primary pneumonic plague","volume":"315","author":"Lathem","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.063_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/IAI.00403-06","article-title":"Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice","volume":"75","author":"Bubeck","year":"2007","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2008.09.063_bib34","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1128\/IAI.73.11.7142-7150.2005","article-title":"Pathogenesis of Yersinia pestis infection in BALB\/c mice: effects on host macrophages and neutrophils","volume":"73","author":"Lukaszewski","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.063_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.83.4.348","article-title":"The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague","volume":"83","author":"Cavanaugh","year":"1959","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.063_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/113.2.139","article-title":"The pathogenesis of plague. I. A study of the correlation between virulence and relative phagocytosis resistance of some strains of Pasteurella pestis","volume":"113","author":"Janssen","year":"1963","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.063_bib37","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.163.3870.950","article-title":"Plague bacillus: survival within host phagocytes","volume":"163","author":"Janssen","year":"1969","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.063_bib38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/IAI.45.3.655-659.1984","article-title":"Yersinia pestis grows within phagolysosomes in mouse peritoneal macrophages","volume":"45","author":"Straley","year":"1984","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.063_bib39","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/IAI.71.10.5892-5899.2003","article-title":"The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis","volume":"71","author":"Pujol","year":"2003","journal-title":"Infect Immun"},{"issue":"36","key":"10.1016\/j.vaccine.2008.09.063_bib40","doi-asserted-by":"crossref","first-page":"12909","DOI":"10.1073\/pnas.0502849102","article-title":"Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus","volume":"102","author":"Pujol","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.063_bib41","first-page":"167","article-title":"Pneumonic plague in monkeys. An electron microscopic study","volume":"54","author":"Finegold","year":"1969","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.063_bib42","first-page":"156","article-title":"Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops)","volume":"120","author":"Davis","year":"1996","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.vaccine.2008.09.063_bib43","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/IAI.73.9.6127-6137.2005","article-title":"Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis","volume":"73","author":"Cowan","year":"2005","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.063_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/mpat.2002.0498","article-title":"Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis","volume":"32","author":"Weeks","year":"2002","journal-title":"Microb Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08013406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08013406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T13:55:37Z","timestamp":1684590937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08013406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":44,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0264410X08013406"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}